{ "cik": 1425205, "cik_padded": "0001425205", "entityName": "IOVANCE BIOTHERAPEUTICS, INC.", "fiscal_years": [ { "accn": "0001104659-26-018899", "filed": "2026-02-24", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 33836000.0, "cash": 163078000.0, "eps_diluted": -1.09, "free_cash_flow": -336244000.0, "net_income": -390978000.0, "operating_cash_flow": -302408000.0, "operating_income": -403356000.0, "revenue": 263502000.0, "stockholders_equity": 698583000.0, "total_assets": 913170000.0, "total_liabilities": 214587000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3071746664319057, "net_margin": -1.4837762142222828, "revenue_growth_yoy": 0.6060340098738344, "roa_avg2y": -0.4287989225683759, "roa_period_end": -0.4281546699957291, "roe_avg2y": -0.5549770473559746, "roe_period_end": -0.5596729379329299 } }, { "accn": "0001104659-26-018899", "filed": "2026-02-24", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 11069000.0, "cash": 115694000.0, "eps_diluted": -1.28, "free_cash_flow": -364046000.0, "net_income": -372177000.0, "operating_cash_flow": -352977000.0, "operating_income": -395278000.0, "revenue": 164070000.0, "stockholders_equity": 710405000.0, "total_assets": 910426000.0, "total_liabilities": 200021000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2815591106481514, "revenue_growth_yoy": 136.98990748528175, "roa_avg2y": -0.4402437459227326, "roa_period_end": -0.40879434462548303, "roe_avg2y": -0.5747827443325112, "roe_period_end": -0.5238941167362279 } }, { "accn": "0001558370-25-001834", "filed": "2026-02-24", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 22290000.0, "cash": 114888000.0, "eps_diluted": -1.89, "free_cash_flow": -384110000.0, "net_income": -444037000.0, "operating_cash_flow": -361820000.0, "operating_income": -460559000.0, "revenue": 1189000.0, "stockholders_equity": 584613000.0, "total_assets": 780351000.0, "total_liabilities": 195738000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3348163656983338, "roa_avg2y": -0.6148679009618973, "roa_period_end": -0.5690221451628819, "roe_avg2y": -0.8190668027975072, "roe_period_end": -0.7595400718081876 } }, { "accn": "0001558370-25-001834", "filed": "2026-02-24", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 20425000.0, "cash": 231731000.0, "eps_diluted": -2.49, "free_cash_flow": -313182000.0, "net_income": -395893000.0, "operating_cash_flow": -292757000.0, "operating_income": -398878000.0, "stockholders_equity": 499638000.0, "total_assets": 663982000.0, "total_liabilities": 164344000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.32892614252718966, "roa_avg2y": -0.5493497257712575, "roa_period_end": -0.5962405607380923, "roe_avg2y": -0.7061340572569087, "roe_period_end": -0.7923596683999216 } }, { "accn": "0001558370-25-001834", "filed": "2025-02-27", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 37574000.0, "cash": 78229000.0, "eps_diluted": -2.23, "free_cash_flow": -265515000.0, "net_income": -342252000.0, "operating_cash_flow": -227941000.0, "operating_income": -342703000.0, "stockholders_equity": 621659000.0, "total_assets": 777333000.0, "total_liabilities": 155674000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.25041702927167464, "roa_avg2y": -0.44281794886889625, "roa_period_end": -0.4402900687350209, "roe_avg2y": -0.5355398436968228, "roe_period_end": -0.5505461997654663 } }, { "accn": "0001558370-24-002036", "filed": "2024-02-28", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 46791000.0, "cash": 67329000.0, "eps_diluted": -1.88, "free_cash_flow": -251925000.0, "net_income": -259581000.0, "operating_cash_flow": -205134000.0, "operating_income": -261937000.0, "stockholders_equity": 656498000.0, "total_assets": 768458000.0, "total_liabilities": 111960000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.17054126592921837, "roa_avg2y": -0.4664054772516357, "roa_period_end": -0.33779464850388696, "roe_avg2y": -0.5433582879193359, "roe_period_end": -0.39540257548385527 } }, { "accn": "0001558370-23-002419", "filed": "2023-02-28", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 6917000.0, "cash": 13969000.0, "eps_diluted": -1.59, "free_cash_flow": -165806000.0, "net_income": -197556000.0, "operating_cash_flow": -158889000.0, "operating_income": -206872000.0, "stockholders_equity": 298971000.0, "total_assets": 344655000.0, "total_liabilities": 45684000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.15280411812516934, "roa_avg2y": -0.47864747127717827, "roa_period_end": -0.5731992862427645, "roe_avg2y": -0.5163755743866675, "roe_period_end": -0.6607864976870667 } }, { "accn": "0001558370-22-001976", "filed": "2022-02-24", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1198000.0, "cash": 82152000.0, "free_cash_flow": -102447000.0, "net_income": -123580000.0, "operating_cash_flow": -101249000.0, "operating_income": -128258000.0, "stockholders_equity": 466193000.0, "total_assets": 480821000.0, "total_liabilities": 14628000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.031377562511663626, "roa_avg2y": -0.3884978481406615, "roa_period_end": -0.2570187242237756, "roe_avg2y": -0.40407144982457976, "roe_period_end": -0.2650833453097751 } }, { "accn": "0001558370-21-001858", "filed": "2021-02-25", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1028000.0, "cash": 145373000.0, "free_cash_flow": -79737000.0, "net_income": -92064000.0, "operating_cash_flow": -78709000.0, "operating_income": -92877000.0, "stockholders_equity": 145481000.0, "total_assets": 155373000.0, "total_liabilities": 9892000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.06799513338511558, "roa_avg2y": -0.5626369328269046, "roa_period_end": -0.5925353825954316, "roe_avg2y": -0.5894000941104165, "roe_period_end": -0.6328249049704086 } }, { "accn": "0001144204-19-010702", "filed": "2020-02-25", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD" }, "fundamentals": { "capex": 1521000.0, "cash": 106717000.0, "free_cash_flow": -34189000.0, "net_income": -52894000.0, "operating_cash_flow": -32668000.0, "operating_income": -53639000.0, "stockholders_equity": 166918000.0, "total_assets": 171886000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "roa_period_end": -0.30772721454917795, "roe_period_end": -0.3168861357073533 } } ], "latest_filing": { "accn": "0001104659-26-018899", "filed": "2026-02-24", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2836", "sic_description": "Biological Products, (No Diagnostic Substances)", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001425205.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001425205.json" }, "ticker": "IOVA" }